The CHMP has advised against EU approval of Eli Lilly's Alzheimer's drug Kisunla, potentially handing an advantage to Eisai/Biogen's rival drug.

Eli Lilly’s $8 billion acquisition of Loxo Oncology looks like it could pay off, with new data for RET inhibitor selpercatinib setting up a filing before the end of the year. The results of the ...

Telugu Panchangam • తెలుగు పంచాంగం Telugu panchangam for any place & date between 1900 and 2050. Accurate panchangam in Telugu and English showing information about the 5 attributes of the day, viz., ...